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Abstract 
Objective: In males a correlation between competitiveness and testosterone have been 
reported. As no such data is available in females we aimed at investigating the possible 
association between competitiveness and androgen levels in a sample of female top athletes. 
Method: Thirty one Norwegian female top athletes completed the competitiveness subscale 
of the Sport Orientation Questionnaire (SOQ), underwent a maximal oxygen consumption 
(VO2max) test with a following lactate measurement and had blood samples drawn to 
measure androstendione and dehydroepiandrosterone sulphate (DHEAS)and compute free 
testosterone index (FTI). Regression analyses were used to investigate the correlation between 
competitiveness and hormone levels. 
Results: No androgens were directly correlated to competitiveness. However, when 
controlling for age, body mass index, VO2max, lactate and sports category, androstendione 
had a significant positive correlation and free testosterone index (FTI) a significant negative 
correlation to competitiveness.   
Conclusion: In female top athletes androstenedione may be positively and FTI negatively 
associated with SOQ measured competitiveness. Further research into to possible association 
between androgens and competitiveness in females are needed to confirm or reject our 
findings. 
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Abbreviations and terms 
 
2D:4D digit ratio: The ratio between the length of the 2nd (index) finger and the 4th (ring) 
finger. 
AIS: Androgen insensitivity syndrome. 
Androgen: Any synthetic or natural compound that produces or stimulates the development of 
male sex characteristics.  
Androgen metabolite: Metabolite of an androgen that have no or markedly reduced ability to 
bind to the androgen receptor and thereby exert androgenic effects. 
Androgen receptor: A receptor in the cell that androgens can bind to.  
Androstanediol: A testosterone metabolite. 
Androstenedione: A weak androgen, it binds less well than testosterone does to the androgen 
receptor. 
BMI: Body mass index. Calculated as body weight in kg / (Height in meters) x (Height in 
meters). 
CET: Cognitive evaluation theory. 
Competitiveness: A disposition to strive for satisfaction when making comparison with some 
standard of excellence in the presence of evaluative others in sport 
CAH: Congenital adrenal hyperplasisa. An inheritable defect in the steroid hormone synthesis 
in the adrenal cortex. Untreated women with the condition have elevated levels of androgens. 
DFD: Sexual differentiation disorders. 
DHEAS: Dehydroepiandrosterone sulphate. A preandrogen that is taken up in the cells where 
it can be converted to androgens as well as estrogens. 
Eugonadal: Normal sex hormone levels 
FTI: Free testosterone index. Calculated as (testosterone/SHBG) × 10. Considered a measure 
of biologically active testosterone.  
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Gonadotrophic hormones: Hormones with a gonadotrophic effect, i.e. stimulating the gonads 
to sex hormone synthesis and/or sex cell production. 
Gonads: Organs producing sex cells and sex hormones, i.e. testicles in men and ovaries in 
women. 
Respiratory exchange ratio: The ratio between amount of CO2 exhaled and O2 inhaled in one 
breath. 
Hyperandrogenism: Usually increased circulating androgen levels. 
Hypogonadal: Low sex hormone levels.  
Hypogonadotrophic hypogonadism: Reduced gonadal function (i.e. low levels of sex 
hormones, in females oestrogen) secondary to reduced pituitary function with low levels of 
gonadotrophic hormones. 
Oligomenorrhea: Experiencing few or no menstruations (menses > 35 days apart or < 10 
menses per year, but less than six months since the last menstruation). 
Organic endocrinopathies: Endocrine disease caused by an inherited or acquired defect in an 
endocrine organ, i.e. high or low levels or increased or decreased biological effect of a 
hormone. 
PCOS: Polycystic ovary syndrome.  
Pseudohermaphroditic: Genetic female with ambiguous or male external genitalia. 
SHBG: Sex hormone-binding globulin. 
SOQ: Sports Orientation Questionnaire. 
Sublingual testosterone: testosterone administered and absorbed from under the tongue 
Testosterone metabolite: Some metabolite of testosterone with markedly reduced or no 
androgen effect, i.e. low or no ability to bind to the androgen receptor. 
VO2max: Maximal oxygen consumption. 
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1. INTRODUCTION 
1.1 Competitiveness 
Competition and competitiveness are important factors in many aspects of social life and the 
arrangement of human societies in general. It is also an important premise, and incentive, for 
participating in competitions and competitive behaviour in general and perhaps the most 
important motivation to participate in sports. Competitiveness has been defined as “a trait that 
is characterized by the enjoyment of interpersonal competition and the desire to win and be 
better than others” (Mowen, 2004). That is a general definition. In connection with sports 
Martens (1976) (referred in Gill & Deeter, 1988, p. 191) states that “competitiveness is 
defined as a disposition to strive for satisfaction when making comparison with some standard 
of excellence in the presence of evaluative others in sport”. 
Literature surrounding this topic generally concludes that men are more competitive 
than women (Dreber & Hoffman, in press). This is true within several areas of human 
societies. Often mentioned examples are different economic decisions. The fact that males are 
more competitive is considered one of the reasons for the existing wage gap between men and 
women (Buser, 2009). Recent experimental economics research concludes that “women tend 
to dislike competition while men actively seek it” (Buser, 2009, p. 2). Why this difference 
exists has yet to be explained, but scientists have hypothesised that there is a possible 
biological basis and that at least part of this biological gender difference may be caused by 
androgens (Gómez-Gil et al., 2008). As stated by Dreber and Hoffman (in press) there is 
strong evidence suggesting that androgens mediate a range of sex differences across animal 
species. 
Androgens affect primary as well as secondary sex differences in animals (Dreber & 
Hoffman, in press). This is true for animals without genetically determined sexes like the 
snapping turtle. More importantly, it is also true for our close relative the rhesus monkey who 
has genetically determined sexes (Dreber & Hoffman, in press). 
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1.2 Short introduction to hormones 
Hormones do not only create the difference in appearance between males and females. It is 
well established that hormones also have major influence on some aspects of human 
behaviour. In both genders major changes in sex hormone levels occur around puberty. In 
males a major rise in testosterone is seen. However, testosterone is only one out of more 
hormones that binds to the androgen receptor and thereby exert androgenic effects at the 
cellular level. All together those hormones are called androgens (Fredberg, 2006).  
Females also have androgens present in their body and blood stream. In females the 
androgen levels are much lower. Even if it is not common, androgens can still create an effect 
on appearance in females. The most important female sex hormone is oestrogen. Oestrogen in 
women acts in many ways as testosterone in men, but with the opposite effect, turning girls 
into women through puberty. However, hormones do not only affect appearance, but also 
behaviour and vice versa. Physical and mental activities, i.e. human behaviour, may also 
affect hormone levels. The present study looks into the possibility that competitiveness in 
women associate with circulating androgen levels.  
 
1.3 Prenatal androgen exposure                                                                           
As already mentioned researches have suggested that the markedly higher testosterone levels 
in men may partially explain the difference in men and women’s level of competitiveness 
(Buser, 2009; Apicella et al., 2008). Apicella et al. (2008) found that higher levels of 
circulating testosterone are associated with a higher level of financial risk taking in men. 
Equally, Sapienza, Zingales & Maestripieri (2009) found that testosterone levels positively 
correlate with financial risk taking. Interestingly, they also found that when controlling for 
current and prenatal testosterone levels the gender gap in seeking a career within finance 
disappeared.  
Controlling for prenatal testosterone is not uncommon. One quite easy way of 
controlling for prenatal testosterone exposure in adults is to look at the 2D:4D digit ratio. The 
2D:4D digit ratio is the ratio between the length of the 2nd (index) and the 4th (ring) finger. 
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Since the bones in the fingers have sex steroid hormone receptors the length of the fingers is 
affected by hormone exposure as a fetus. Especially the 2D:4D digit ratio has been found to 
be negatively associated with prenatal testosterone exposure. The 2D:4D digit ratio is lower in 
men than in women (Manning, Scutt, Wilson & Lewis-Jones, 1998; McIntyre, 2006). This 
fact supports the view that androgens are involved.  
Together with the 2D:4D digit ratio Sapienza et al. (2009) used another measure to 
control prenatal testosterone levels even better. Since prenatal testosterone exposure also has 
been found to affect sociability and the ability to empathize with other individuals, testing for 
that could help determining the prenatal testosterone exposure. To test this the “Reading Mind 
in the Eyes” test developed by Baron-Cohen was used. In the Baron-Cohen test participants 
are shown 34 pairs of eyes and told to guess the feeling that is expressed. Low prenatal 
testosterone exposure is associated with higher performance on the test, and men normally 
score lower than women (Sapienza et al., 2009).  
 Only studies investigating the effect of active intervention that decreases or increases 
testosterone levels can reveal if a cause and effect relationship exists. In females such studies 
with testosterone are ethically challenging. However, sometimes nature itself makes the 
experiments for us. An example is congenital adrenal hyperplasia (CAH), an organic 
endocrinopathy with an inherited defect in the synthesis of steroid hormones in the adrenal 
cortex. In women it results in elevated circulating levels of androgens during fetal life. These 
women are generally diagnosed and treated soon after birth. However, some with a mild 
defect may be diagnosed after menarche or go through life undiscovered. When treated they 
have normal androgen levels. Accordingly, women with CAH can be used as a model to 
investigate long term effects of increased androgen exposure during fetal life. Women with 
CAH tend to be lonelier than their female counterparts and more uncertain about their gender 
identity (Beltz, Swanson & Berenbaum, 2011; Berenbaum, Bryk & Beltz, 2012; Meyer-
Bahlburg, 2011; Pasterski et al., 2011). This indicates that androgens have important lasting 
effects on important aspects of human life. 
In animals as well as humans, too high prenatal testosterone levels will cause genetic 
females to show male forms while too low levels of prenatal testosterone will cause males to 
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show female forms. This will be discussed further in a later section as it may be an advantage 
for females to have male characteristics when competing on a high level in sports. 
 
1.4 Testosterone and cognitive function 
According to Stanton et al. (2011) a number of studies have shown a link between male risk-
taking behaviour like committing crime, participating in high-risk sports and physical 
aggression and androgen levels. Men do on average have approximately ten times higher 
androgen levels than women. Androgens cause some of the gender differences in muscle mass 
as well as performance on different non-physical tasks like spatial ability, mazes and reading 
maps (Dreber & Hoffman, in press; Voyer, Voyer & Bryden, 1995).  
It has been hypothesized that not only organisational effects sex hormones has in the 
brain contribute to the sex differences seen in cognition between males and females. Studies 
looking at the relationship between cognitive function and testosterone levels have found a 
correlation between the two that indicates as role in sex differences in cognition (Durdiakova, 
Ostatnikova, & Celec, 2011). Therefore, not only organizational, but also activational effects 
of testosterone and other androgens may play an important role in explaining the sex 
differences. 
 
1.4.1 Testosterone and cognitive function in men 
Studying testosterones effect on cognitive function most studies seem to only include males 
while comparing two or more groups. Examples are age groups, comparing younger and older 
groups, or eugonadal (i.e. normal sex hormone levels) and hypogonadal (i.e. low sex hormone 
levels) groups. Experimental studies on men have, as mentioned, suggested beneficial 
changes in cognitive function when supplying testosterone (Aleman, Bronk, Kessels, 
Koppeschaar  & van Honk, 2004). 
 Comparing older and younger groups is another way of trying to understand how 
hormones like testosterone and oestrogen affect humans without using hormones as a 
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treatment since hormone levels tend to change with age in both genders (Dorgan et al., 1995). 
However, with such a study design it may be difficult to sort out the effect of aging itself.  
Several researchers have found associations between testosterone levels and 
visuospatial abilities in elderly individuals as well as young adults, although mostly in male 
subjects (Aleman et al., 2004; Gómez-Gil et al., 2008).  
 
1.4.2 Testosterone and cognitive function in women 
In women, research suggests that higher testosterone levels are related to better performance 
on mental rotation tasks and improved visouspatial abilities, like in men. Aleman et al. (2004) 
aimed to investigate if a single dose of testosterone would enhance female’s performance on a 
task that has been associated with male superiority. Twenty-six females took part in their 
study on mental rotation demonstrating that a single administration of 0.5 mg of sublingual 
testosterone (testosterone administered and absorbed from under the tongue) improved 
visuospatial abilities in young women 4-5 hours after intake. This indicates that testosterone, 
in addition to long term effects from intrauterine exposure, have more immediate effects, i. e. 
activational effects on brain functions in women also.  
According to Postma et al. (2000) in their sample of fifteen females a single 
administration of 0.5 mg testosterone had an effect on some aspects of spatial memory. The 
conclusion was that testosterone may have some activational effect on certain aspects of 
spatial memory, but they are small and in need of further research.  
 However, results are inconclusive in women as well as in men (Gómez-Gil et al., 
2008). Halari et al. (2005) found no sex differences in cognitive performance between men (n 
= 42) and women (n = 42) that were related to a variety of hormones (testosterone, oestradiol, 
progesterone, luteinizing hormone, follicle-stimulating hormone, and sex hormone binding 
globulin, as well as among women during the follicular phase of the menstrual cycle). Men 
were better at spatial tasks like mental rotation and judgement of line orientation, as well as an 
inhibition task. Women on the other hand were better at the verbal tasks (represented by 
category fluency in the study). No significant relationship between any of the hormones and 
cognitive performance was found. That suggests that there are few, or no, substantial 
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relationships between endogenous, nonfluctuating levels of gonadal hormones or 
gonadotropins and the cognitive tasks used in the study (Halari et al., 2005).  
 
1.5 Testosterone effects on behaviour 
Testosterone is widely studied and has been linked to several real-world domains since it was 
isolated and identified in the 1930s (Mazur & Booth, 1998). According to Mazur and Booth 
(1998) it was early hypothesised that testosterone and aggression was correlated as Allee, 
Collias and Lutherman in 1939 gave testosterone to low ranked hens. The hens became 
aggressive, rose in the hierarchy and showed an increase in male characteristics. Later it has 
become clear that testosterone has major behavioural effects on human males prenatally (in 
the uterus and shortly after birth) as well as during puberty and in adulthood (Mazur & Booth, 
1998).  
 In a study done by Cashdan (1995) it was reported that testosterone was negatively 
correlated with status judged high by their college peers. The females self-assessed high 
status was positively correlated to testosterone. Testosterone also had a negative correlation 
with smiling frequency which can be an indicator of dominance (Cashdan, 1995).    
 Stanton et al. (2011) studied the relationship between testosterone and economic 
decision making. They included a large number of males (n = 142) and females (n = 156) in 
their study and found that women were more risk averse and more ambiguous than men. They 
also reported that individuals with high or low testosterone levels were risk and ambiguity 
neutral, and individuals with intermediate levels were risk and ambiguity adverse. The 
relationship between testosterone and risk preference was similar for women alone. 
 
1.5.1 Testosterone and aggression  
 Dominant behaviour and aggression, which may be important factors in sports and 
competition, have been linked to testosterone (Archer, 2006; Hermans, Ramsey & van Honk, 
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2008; Mazur & Booth, 1998). Androgens seem to act on specific substrates and areas in the 
brain increasing aggression and motivation for competition (Gleason, Fuxjager, Oyegbile & 
Marler, 2009; Hermans et al., 2008). One interesting example is found in humans’ close 
relative the rhesus monkey. Normally young males participate in more and rougher tumble 
play and threatening behaviour than young females. When pregnant monkeys are treated with 
high doses of testosterone the female offspring tend to become pseudohermaphroditic (genetic 
females with ambiguous or male external genitalia) and show typical male play behaviour. 
Treating pregnant rhesus monkeys in the later part of gestation, instead of the early part, gives 
female offspring with the same typical male-type playing patterns, but normal female genitals. 
This illustrates organizational effects of testosterone also in female foetuses with lasting 
effects on behaviour. Further, this shows that genital and behavioural masculinisation is 
independent from one and other and that different effects occur during specific time windows 
during intrauterine life (Mazur & Booth, 1998). Researchers think that several prenatal 
hormone effects are organizing the architecture of the body and brain. Later in life the same 
hormones are thought to activate structures in the body and brain (Durdiakova et al., 2011).   
Testosterone levels increase in males during puberty and causes male characteristics to 
appear. When puberty is passed, the boy is changed into a man from a physical standpoint. 
Normal male testosterone levels do not further influence behaviour by major reorganization of 
the body (Mazur & Booth, 1998). However, fluctuating levels of circulating testosterone in 
the blood stream may activate receptors in different organs and the nervous system to, maybe, 
affect domination and aggressive behaviour. For ethical reasons aggression in humans are 
mostly measured with different types of personality questionnaires. Although a few 
researchers have found positive correlations between aggression and testosterone “it seems 
clear that testosterone is not related in any consistent way to aggression as measured on 
common personality scales” (Mazur & Booth, 1998, p. 365). Both Mazur and Booth (1998) 
and Archer (1991) agree upon the fact that studies using self-assessed aggressive 
predispositions and traits are of limited relevance and that the focus should be more towards 
concrete indicators of behaviour. That testosterone is associated with both aggressive and 
dominating behaviour, as well as the willingness to take risks could be an indication that an 
increase in testosterone levels lead to a decrease in risk aversion (Stanton et al., 2011). 
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Testosterone has also been positively linked to the willingness to take risks in social domains 
in both men and women (Stanton et al., 2011).  
 
1.5.2 Testosterone and aggression in women 
Researchers have speculated that testosterone may be associated with aggression and status in 
women as well as men. However, literature on the topic is sparse and the few studies that are 
found have been conducted in very different ways. Accordingly, the results are hard to 
compare. Despite that, Purifoy and Koopmans (1979) found that serum androstenedione, 
testosterone, testosterone‐binding globulin (SHBG) and free testosterone levels correlated 
with the status of the occupation when including fifty-five normal females in their study. 
Androstendione and free testosterone levels also correlated positively with the job 
complexity.  
Dabbs, Ruback, Frady, Hopper and Sgoutas (1988) found no difference in mean 
testosterone between eighty-four female prisoners and fifteen college students. However, they 
did find that testosterone differed among groups of prisoners according to the crime they had 
been convicted of. Women convicted of unprovoked violence had higher testosterone levels 
than the other prisoners. Further, Dabbs and Hargrove (1997) included eighty-seven female 
prisoners in a new study but were unable to find any significant correlation between salivary 
testosterone levels and criminal violence. Instead they found that aggressive dominant 
behaviour in prison and salivary testosterone was significantly correlated. However, it should 
be noted that salivary testosterone associate poorly to testosterone levels in blood (Broadbent, 
2002; Granger, Shirtcliff, Booth, Kivlighan and Schwartz, 2004). 
It has also been reported that aggressive female patients in a neurological clinic had 
higher testosterone levels than the non-aggressive patients. However, the patients also 
suffered from different diagnosis so comparing them could be discussed (Mazur & Booth, 
1998).  
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1.6 Behavioural effects on testosterone levels 
It is well established that males’ testosterone levels react to competition. Studies in male 
athletes show that testosterone variation before and after sports competition relates to the 
outcome of the competitions. Male athletes’ testosterone is slightly elevated before the 
competition, as in anticipation. Winning a competition elevates testosterone levels one or two 
hours after the match compared to testosterone levels of the losers (Booth, Shelly, Mazur, 
Tharp & Kittok, 1989). The same pattern of change in testosterone levels is seen in response 
to symbolic challenges and status change among men and is true for physical as well as non-
physical competition (Mazur, Susman & Edelbrock, 1997). These data indicates that 
psychological mechanisms are involves in the regulation of human circulating testosterone 
levels, at least in men. The physiological mechanism is essentially unknown. However, the 
sympathetic nervous system may be involved (Fry, Schilling, Fleck & Kraemer, 2011). 
To study if the same pattern was true for females Mazur et al. (1997) used data from 
twenty-eight males and thirty-two females. Salivary testosterone levels were measured before, 
during and after competing against a same sex individual in a video game. In males the 
normal pre competition elevation in testosterone was present, but not in females. Further, 
males did not have the expected rise in testosterone when winning. This was explained by the 
fact that winning or losing did not create a mood difference in the males. The mood difference 
was found in the females, but was not accompanied by a change in testosterone levels (Mazur 
et al., 1997). Also in soccer games winning or losing have been observed to induce the same 
changes in salivary testosterone levels (Edwards, Wtzel & Wyner, 2006). However, in a well 
designed study salivary testosterone levels in female soccer player responded differently to 
winning or losing (Oliveira, Gouveia & Oliveira, 2009). In winners it was positive and in 
losers negative. Furthermore, the changes in mood and anxiety found between winners and 
losers paralleled the changes in salivary testosterone levels. The authors hypothesised that 
contest induced mood changes may influence the testosterone response. 
In 2010 Carney, Cuddy and Yap found that imagining being in a power position for a 
short while can increase the testosterone levels when including twenty-six females and sixteen 
males in their study. Testosterone (and other hormones) was measured through saliva samples 
before and after the participants did the high-and low-power poses. High-power poses caused 
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increased testosterone compared with low-power poses, which caused a decrease in 
testosterone. Men and women were not analysed as separate groups. 
In oral contraceptive users a decrease in salivary testosterone was observed. However, 
the changes associated with competitions were conserved (Edwards & O’Neil, 2009). All 
together this indicates that the physiological testosterone response to winning a competition is 
not gender specific.  
Testosterone levels vary both between individuals as well as within one individual 
depending on outside stimuli and events (Wood & Stanton, 2012). According to Wood and 
Stanton (2012) there is a possibility that individuals with higher testosterone values have an 
increased motivation and desire to compete in sports due to testosterones positive influence on 
power motivation. High testosterone concentrations are positively linked to seeking into 
power-laden careers like trial law etc. Power motivation in males is positively correlated to 
testosterone while in females it is positively correlated to the female sex hormone oestradiol 
(Schultheiss, Dargel & Rohde, 2003; Schultheiss et al., 2005; Stanton & Schultheiss, 2007; 
Stanton & Edelstein, 2009). Power-motivated individuals find dominance experiences 
rewarding and are therefore motivated to pursue dominance. It is thus likely that high 
testosterone individuals of both sexes may be more motivated to pursue athletic competition 
and sports than other normal or low testosterone individuals (Wood & Stanton, 2012). 
 
1.7 Females, competitiveness and hormones 
When preparing for this research project it became clear that only a few studies have looked 
at the relationship between competitiveness and hormones in women, and rarely so in a sports 
setting. Most studies in the field of female competitiveness seems to be comparing women 
with men and whether or not the competitive gender differences found within the economical 
field are caused by hormones, in particular testosterone.  
However, a study by Metha, Wuehrmann and Josephs (2009) investigated the effect 
testosterone has on general competitive performance depends on if it is an individual 
competition among individuals or an intergroup competition amongst teams. Included in the 
study were an equal number of men and women gave saliva samples before completing an 
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analytical reasoning test, either in same sex pairs or separately. Interestingly, there was a 
positive relationship between performance and testosterone in the individual competition and 
a negative relationship between performance and testosterone in the cooperation setting. This 
was true for both genders. 
Buser (2009) points out that female sex hormones also may play an important role in 
explaining the gender differences in competitiveness. This assumption is based on the 
observation that women are significantly less competitive while taking contraceptives 
containing oestrogen and/or progesterone or during parts of the menstrual cycle when 
oestrogen and in particular progesterone levels are especially high. Buser (2009) measured 
competitiveness through letting the participants chose between a tournament and non-
tournament reward system when solving math questions. He assumed that the less competitive 
individuals would chose the non-tournament reward system, while the competitive ones 
would chose the tournament reward system. He found that progesterone had a negative impact 
on competitiveness and that women were more competitive during the pill break than when 
taking the pill. The conclusion was that women’s behaviour shifts more towards men’s 
behaviour when female hormone concentrations are low. Buser (2009) also stated that 
testosterone levels may have an effect on competitiveness and that further research into the 
mechanisms underlying hormonal effects on competitiveness is needed. In conclusion, 
endocrine factors and in particular sex hormones, seem to play an important role in explaining 
the gender differences in competitiveness. Rickenlund et al. (2003) found that girls with 
higher androgen levels in general had the highest maximal oxygen consumption (VO2max) 
values and the highest general performance values.  
Finding statistical associations between different behaviours and personal traits and 
hormone levels does not prove a cause and effect relationship. Interestingly, Zethraeus et al. 
(2009) conducted a large randomised double blind placebo controlled study. Two hundred 
post menopausal women between 50-65 years of age were treated with testosterone, oestrogen 
or placebo for four weeks. At the end of the study there were no differences in altruism, 
reciprocal fairness, trust, trustworthiness, and risk attitudes (Zethraeus et al., 2009).  
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1.8 Hormones and menstruation in female athletes 
1.8.1 Menstrual disturbances 
High performance sports may reduce the ovarian function by suppression of the 
gonadotrophin releasing hormone (GnRH) at the hypothalamic level (Aebersold-Schütz, 
1997; Warren & Perlroth, 2001). The traditional presumption is that female athletes’ loss of 
normal menstrual cycles is a result of an insufficient dietary intake leading to caloric deficit. 
This deficit initiates a cascade of effects at the hypothalamic, pituitary and ovarian level 
eventually leading to oligo- or amenorrhea (having a few or no menstruations) and eventually 
reduced circulating oestrogen levels (hypogonadotrophic hypogonadism). Contrary to the 
common belief that hypogonadotrophic hypogonadism was the dominating cause of 
oligoamenorrhea in female athletes Hagmar, Berglund, Brismar and Hirschberg (2009) and 
Rickenlund et al. (2003) found increased proportions of women with hyperandrogenism and 
PCOS among female athletes.  
 
1.8.2 Polycystic ovary syndrome  
Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder affecting as much 
as 15-20 percent of women in reproductive age (Badawy & Elnashar, 2011). It is a syndrome 
characterised by menstrual disturbances and hyperandrogenism. In particular testosterone 
tends to be elevated in most of the women affected by the syndrome. To get the diagnosis of 
PCOS at least two out of three criteria have to be fulfilled: 1) Oligo- or amenorrhea, 2) 
Hyperandrogenism, clinically or biochemically, and 3) Polycystic ovaries (Rotterdam 
ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004). PCOS is closely linked 
to insulin resistance and the metabolic syndrome. Accordingly, women affected by PCOS 
have an increased likelihood of adiposity, impaired glucose tolerance (IGT) and diabetes type 
2 (DM2). Genetic studies have so far failed to identify any gene that substantially increases 
the risk of having PCOS (Badawy & Elnashar, 2011). 
Over the last two decades scientists have studied the fetuses intrauterine 
environmental exposures (both hormones and nutrition) and linked them to long term health 
  
16 
 
effects as a child, teenager and adult (Swanson, Entringer, Buss & Wadhwa, 2009). Animal 
studies in monkeys and sheep amongst others have shown that female fetuses exposed to 
elevated testosterone levels during intrauterine life, develop a condition when they reach 
fertile age that is very similar to human PCOS (Xita & Tsatsoulis, 2006). Accordingly, it is 
hypothesised that increased androgen exposure during fetal life predispose to PCOS and 
hyperandrogenism as an adult. One hypothesis is that a placental dysfunction may cause the 
increase in placental androgen secretion that in turn affects the fetus.  
Interestingly, PCOS women tend to have more minor psychiatric problems than non-
PCOS women. Women with facial hirsutism, a clinical manifestation of hyperandrogenism, 
have a high prevalence of eating disorders and eating disorders were linked to PCOS 
(Morgan, Scholtz, Lacey & Conway, 2008). In bulimic women an increased prevalence of 
PCOS was found (Naessén, Carlström, Garoff, Glant & Hirschberg, 2006). The hirsutism 
score and indices of biological testosterone effects associated with bulimia. This is in 
accordance with an earlier study that found that one third of women with PCOS had abnormal 
eating patterns and 6% had scores suggestive of bulimia compared to only 1% of women with 
organic endocrinopathies (McCluskey, Evans, Lacey, Pearce & Jacobs, 1991). However, 
others have failed to link eating disorders to PCOS (Michelmore, Balen & Dunger, 2001). 
In hyperandrogenic patients with bulimia nervosa treatment with an oral contraceptive 
(OC) with antiandrogenic properties reduced binge eating behaviour (Naessén, Carlström, 
Byström, Pierre & Hirschberg, 2007). An adverse effect of testosterone on eating behaviour 
was proposed. 
  
1.8.3 Androgen insensitivity syndrome 
Androgen insensitivity syndrome (AIS) is another, more rare, syndrome that may affect and 
improve physical performance. AIS is a syndrome where individuals are genetically males, 
i.e. have a male chromosomal sex, but phenotypically have a typical female appearance and a 
strong female gender identity (Freberg, 2006). However, subjects with AIS are not completely 
phenotypically females as some parts of the female sexual features (ovaries and uterus) are 
underdeveloped. Despite normal circulating androgen levels the tissue does not develop 
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normally to a male phenotype due to an absent intracellular androgen effect. In short, 
individuals with AIS end up having male chromosomes while looking like women. Normally 
this happens in 1 of 60 000 male births. However, in sports 1 in 500 women competing in 
international sports levels may have AIS (Fredberg, 2006). These seemingly advantages effect 
of AIS is suspected to be secondary to the insufficient development of the ovaries which are 
essential in synthesising female hormones. Female hormones may play an important role in 
differentiating between males and females when it comes to sport achievements.  
Also disorders of sexual differentiation (DSD) other than AIS may cause elevated 
concentrations of endogenous androgens, potentially creating a competitive advantage for 
females competing in sports (Wood & Stanton, 2012).  
 
1.9 Motivation and competitiveness 
As mentioned above competitiveness is defined as a trait that is characterized by the 
enjoyment of interpersonal competition and the desire to win and be better than others. 
Competitiveness is an important premise for taking part in competitive sports. The motivation 
for participating in competition in general and sports competition in particular is not the same 
for all individuals even if the goal is to win and be better than others. Sports are so much more 
than just fun and games, there is a lot behind it. From running around the schoolyard to old 
boys’ soccer, world championships and Olympic Games in different sports, it is all motivated 
by something. To become a top athlete takes a lot of work and a whole lot of training. To go 
through with a lot of work and a lot of training an individual has to be motivated for the task 
at hand.  
 
1.9.1 The self-determination theory 
One specific theoretical perspective attempting to explain the relationship between 
competition and motivation is self-determination theory (Deci & Ryan, 1985). The self-
determination theory is not sport specific, but here it will be explained in a sports setting. 
Self-determination assumes that human beings and our behaviour are motivated of three 
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psychological needs being autonomy, competence and relatedness with others. The need for 
autonomy is fulfilled when individuals participate in an activity, in this context sports, of their 
own free choice. Challenging an individual’s skill level, at the right amount, will cause the 
individual to develop its abilities and build confidence. Seeing its own increased competence 
and self-determination then creates intrinsic motivation. Intrinsic motivation is according to 
Deci and Ryan (1985) a key outcome of self-determination. Seen from a sports perspective 
self-determination theory focuses on how intrinsic motivation influences individuals to 
develop, persist and compete in sports (Frederick & Ryan, 1993). When an individual engages 
in sports by its own free will and is challenged at the right level, when the task at hand does 
not feel too easy or too difficult, it feels challenged but still capable of overcoming the 
challenge. The competence and autonomy the athlete gains may motivate him or her to train 
for hours and hours to improve and become as perfect as possible, all with no apparent 
reward. The individual’s intrinsic motivation level reflects self-determination and can be 
influenced by the athlete’s participation environment in the form of received performance 
feedback or the reward structure of the competition or activity. 
Not all sports activities are intrinsically motivated. Extrinsically motivated sports 
activities are not freely chosen by the individual, or not challenging or too challenging. One 
example everyone can relate to is gym classes at school. A lot of human behaviour starts with 
extrinsic motivation and moves towards greater self-regulation with time. Parents’ pushing 
their kids into different types of after school activities and sports programs is just one 
example. Sometimes the kids then quit when given the opportunity to make their own choice, 
while others chose to stick with it. Extrinsically motivated sports activities can go though 
three levels of internalization as the individuals’ self-determination increases (Deci & Ryan, 
1985). The first one is external regulation where the behaviour is controlled and forced 
directly by an external source. Introjected regulation is the next level where the former 
external control is internalized so that the behaviour is motivated by a desire to avoid social 
disapproval and gain approval. In the third level the individual is finally motivated by its own 
interest, ability and desire to achieve self-initiated goals. Identified regulation, as it is called, 
is therefore characterized by a high level of self-determination and internalization (Frederick-
Recascino & Schuster-Smith, 2003).  
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When it comes to sports, intrinsic motivation correlates positively with training hours 
and days per week. The same is true for the activities levels of perceived satisfaction and 
competence the athlete feels. Extrinsic motivation has a positive correlation with anxiety, and 
a negative correlation to self-esteem (Frederick and Ryan, 1993). According to Hodgins, 
Yacko, Gottlieb, Goodwin and Rath (2002) (referred in Frederick-Recascino & Schuster-
Smith, 2003) athletes motivated by autonomous motivational states performed better than 
those motivated by extrinsic states. Deci and Ryan (1985) and Frederick-Recascino and 
Schuster-Smith (2003) supports the fundamental assumption of the self-determination theory 
which sees motivation as the driving force of psychological as well as behavioural outcome 
within real-life domains. That again suggests that differences in motivation lead to differential 
levels of participation and/or psychological outcomes for athletes and not the other way 
around (Frederick-Recascino & Schuster-Smith, 2003). 
 
1.9.2 The cognitive evaluation theory 
When using self-determination theory in a sport setting it is normally done on the background 
of the cognitive evaluation theory (CET), a sub-theory of self-determination theory (Deci & 
Ryan, 1985). It addresses how external factors like feedback, reward, choice and competition 
are interpreted within sports and predicts how the same factors enhances or undermines 
intrinsic motivation. CET says that athletes can interpret sport and exercise performance 
informationally or in a controlling way. A competition, or other event, having many rules, 
rigid structure and even punishment, it is considered to be a highly controlling competition 
and limit the athletes autonomy. That again makes the athlete perceive the competition as 
facilitating external causality and result in lower intrinsic motivation. A competition, or event, 
being the complete opposite with less external control and only a few rules, no rigid structure 
and no punishment would demand high intrinsic motivation and give an increased likelihood 
of adherence to the activity. Sources of motivation being outside the individual may lead to 
increased extrinsic motivation, unachievable goals or even quitting the sport completely 
(Frederick-Recascino & Schuster-Smith, 2003).  
When athletes interpret the competition, or event, as a way of gaining information it is 
referred to as an informational perspective. Reviewing competitions personally gives the 
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athlete positive or negative feedback about the results. Incompetence is often interoperated 
from a negative perspective, while a positive interoperation promotes competence. Also here 
it depends on the competition/event and how controlling it is. Positive information taken from 
a controlling competition strengthens extrinsic motivation letting the controlling surroundings 
be more important than the positive feedback and therefore the athlete is no longer 
autonomous in initiating the decision making. Once again extrinsic motivation is reinforced 
by nonself-determining surroundings. Negative feedback in the same setting would suggest 
incompetence and result in learned helplessness as it undermines intrinsic and extrinsic 
motivation (Ryan, Vallerand & Deci, 1984).  
Fortier, Vallerand, Briere & Provencher (1995) found that competitive athletes had 
lower intrinsic motivation and higher identified regulation and amotivation, than recreation 
athletes. Amotivation is a state of unwillingness where the athlete lacks the intention to act. It 
is often a result of not feeling competent enough or not believing that it will produce the 
desired result (Ryan & Deci, 2000). Competition has a possibility of harming intrinsic 
motivation. When the focus of the competition becomes winning, as Fortier et al. claimed was 
the case for athletes, the extrinsic motivation takes over. In other words, the more serious the 
athlete takes the sport and competitions the more likely is it that he or she is mainly motivated 
by extrinsic factors. Recreational athletes are more likely to be intrinsically motivated and 
participate in sports for the fun of the sport itself. It is important to add that, as Fortier et al. 
(1995) states, most athletes are likely to at some point have started his or her sport due to 
intrinsic motivation, but as the competitions get more and more serious, winning becomes 
more important and for many ends up being the main objective.  
Fortier et al. (1995) interpreted the results as a support to CET saying that the 
competitive environment can affect intrinsic motivation. For competitive athletes the goal and 
focus is winning, and success is measured after that standard giving them a personally 
controlling environment and external causality. Other studies confirm this finding (Frederick-
Recascino & Schuster-Smith, 2003). 
The athletes own perceived competitiveness is important within CET. In sports 
situations athletes judge how they perceive the competition, competitive environment, their 
own thoughts and behaviour. Athletes being task-oriented find it easier to maintain their 
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intrinsic motivation as they focus on the challenge at hand and process of the competition. 
They find the experience and feelings the sport give them important no matter if they win or 
lose. Outcome-oriented athletes focus on the result of the competition, in other words if they 
win or lose and compare themselves to others. They are more extrinsically motivated 
(Frederick-Recascino & Schuster-Smith, 2003). In their own study Frederick-Recascino & 
Schuster-Smith (2003) found that sport specific competitiveness (measured with the Sport 
Competition Trait Inventory) was positively correlated with intrinsic motivation while general 
competitiveness was related to lower levels of intrinsic motivation in cyclists. The results 
were interoperated as supping CET saying that the competitive environment can have great 
influence on the athlete motivation style.  
White and Duda (1994) used the Task and Ego Orientation Questionnaire and found 
that males were significantly higher in ego-orientation than females. The group consisting of 
athletes was more ego-oriented than the other groups (consisting of youth, high school kids, 
intercollegiate and individuals using sports for recreational reasons). High ego-oriented 
individuals were more likely to participate in sports for the competition, potential recognition 
and status, and less likely to emphasize team membership. The task-oriented individuals 
related positively to the importance of skill development and fitness as reasons to participate 
in sports.  
 
1.10 Gender and competitiveness 
Using SOQ (Sports Orientation Questionnaire) difference in the level of competitiveness has 
been found between students entered in competitive and non-competitive activity classes (Gill 
& Deeter, 1988; Gill & Dzwaltowski, 1988). Martin, Eklund and Smith (1994) claim that 
male runners are more competitive than their female counterparts but when checking the 
reference given no such information is available in the cited paper (Martin & Gill, 1991). Gill 
(1993) did however study gender differences on competitiveness and found that males 
participate more in competitive sports and score higher on competitiveness than females do.  
Cashdan (1998) used competition diaries among university students and found that 
men talked more about competition within the same sex than females and competed more in 
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sports than females. Males also used physical, but not verbal, aggression more often. Females 
competed more about looking attractive compared to other women. When measuring the 
strength of competition with a questionnaire Cashdan found that males and females over all 
felt the same degree of competitiveness. Males felt more competitive than females about 
sports and sexual attention, while females felt more competitive about looking attractive. 
Cashdan (1998) also reports that young males were more competitive than older males, as 
well as more aggressive (physically and verbally). No age difference in competitiveness was 
found in women. 
 
1.11 A lack in research 
Despite indirect data indicating that there might be a relationship between circulating 
androgens and competitiveness we did not find any  research looking at the possible 
relationship in female athletes through the extensive literature search for this project. And no 
data are available on the possibility that differences in competitiveness between athletes and 
non-athletes may be explained by differences in androgen levels. Yet, researchers have 
pointed out that women with PCOS and AIS are both overrepresented in sports competitions 
and that these syndromes might be an advantage when competing (Fredberg, 2006; Hagmar et 
al., 2009; Rickenlund et al. 2003). It has been pointed out that males, who on average have 
approximately ten times higher testosterone levels than women, are more competitive and 
stated that more research into the field is needed. However, close to nothing has been 
published on female athletes, competitiveness and androgens.  
 
1.12 Aim of the study 
The aims of the study was to investigate in females athletes the possible association between 
self esteemed competitiveness measured with the Sport Orientation Questionnaire’s 
competitiveness subscale and circulating androgens represented by serum testosterone, 
androstenedione and dehydroepiandrosterone sulphate (DHEAS). Our hypothesis was that: 
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among female top athletes competitiveness is positively associated with circulating  
androgen levels.  
 
2. METHODS 
2.1 Literature search   
The databases PsycINFO, Scopus, Web of Science and Embase were searched by the use of 
the search terms competition or competitive ability combined with human sex differences or 
hormones or endocrinology or sex hormones/ or adrenal cortex hormones or athletic 
performance or athletes or athletic participation or sports or sport psychology. The last search 
date was 18th of April 2012. Only human studies were included. After searching the abstracts 
we were left with 55 papers of possible interest. The reference lists of these papers were also 
screened. 
 In addition to that, as the paper grew in extent sources were needed to help explain 
how hormones work in general, what and how VO2max, lactate, BMI and age are related to 
competitiveness. That was found by looking through the reference list of the articles that were 
already found as well as special searches designed to find specific explanations 
 
2.2 Participants 
The participants were 36 female athletes supported by Olympiatoppen Midt-Norge, an 
organisation supporting top athletes in Mid-Norway. Four of the 36 had to be excluded due to 
missing blood samples and one due to a lack of VO2max data, leaving 31 participants for the 
data analysis.  
The athletes were between 18 and 34 (M = 22.6 ± 3.6, Mdn = 21) years old. In Figure 
1 a graphical picture of participants’ age distribution is given. This is done because neither 
mean age nor median gives a good picture to describe the age distribution in the group. Out of 
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the 31 participants 22 practiced soccer and 9 cross country skiing, all competing on 
international or national levels.  
 
Figure 1. Age distribution of the participants.  
 
2.3 Measures 
2.3.1 Questionnaires 
Sport Orientation Questionnaire (SOQ). SOQ was developed by Gill and Deeter in 1988. 
The goal was to develop an instrument that was appropriate to use on athletes, non-athletes, 
males and females and individuals who participated in different competitive and non-
competitive sport activities. SOQ has three subscales; competitiveness, win orientation and 
goal orientation which can be seen as separate factors. The competitive subscale has 13 items, 
the goal orientation subscale has 6 items and the win orientation subscale has 6 items. Only 
the 13 competitiveness subscale items were included in our questionnaire (Appendix 1). Gill 
and Deeter (1988) found that the competitiveness score differentiated between students 
enrolled in competitive classes and those in non-competitive classes. It also differentiated 
between individuals participating in competitive sports while other more general 
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competitiveness measures failed to demonstrate the same differences. SOQ is a 5-point 
Likert-type scale with 25 statements describing reactions to different sport situations. Gill 
(1993) stated that in females SOQ represented the strive for success and satisfaction, in other 
words, competitiveness.  
  Internal consistency was estimated by Gill and Deeter (1988) to be 0.94 and construct 
and concurrent validity have been adequately demonstrated (Houston, McIntire, Kinnie & 
Terry, 2002). The questions were translated to Norwegian by one subject and the translation 
validated by translation back to English by another subject unaware of the original English 
questions. 
The competitiveness subscale consists of 13 questions, each with 5 possible answer 
ranging from strongly agree (score = 5), slightly agree (score = 4), neither agree nor disagree 
(score = 3), slightly disagree (score = 2) and strongly disagree (score = 1). The scores on all 
the questions are summarized representing the competitiveness score. This gives a possible 
over all competitiveness score ranging from 13 in the least competitive subjects to 65 in the 
most competitive subjects. 
 
2.3.2 Hormones 
Blood samples were drawn from an antecubital vein between 08 and 10 am after an overnight 
fast. Serum was stored at -20 degrees centigrade for a maximum of 14 days before transferred 
to a -80 degrees centigrade freezer.   
For serum testosterone and androstenedione analyses, organic solvent extraction 
(dichloromethane for testosterone and ethyl ether for androstenedione) was used before 
quantification. Androstenedione was measured with a competitive immunoassay based on the 
use of antibody-coated tubes, the Coat-A-Count
®
 Direct Androstenedione procedure, using 
reagents and calibrators supplied by the manufacturer Siemens Medical Solutions Diagnostics 
(Los Angeles, CA, USA). 17-hydroxy-progesterone, sex hormone-binding globulin (SHBG), 
testosterone, and dehydroepiandrosterone sulphate (DHEAS) were all measured using an 
enzyme-linked immunosorbent assay (ELISA) for quantitative determination in serum. Intra-
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assay coefficients of variation were 1.8 % for 17-hydoxy-progesterone, 5.6 % for 
androstenedione, 2.8 % for DHEAS, 6.6 % for SHBG, and 9.5 % for testosterone. All samples 
were measured in duplicates and the mean of the two measurements were used in all 
estimations. The free testosterone index (FTI) was calculated as (testosterone/SHBG) × 10. 
In the present study androstenedione and testosterone were analysed after a 
precipitation of the serum to be analysed. This procedure was undertaking to separate out 
water soluble androgen metabolites that tend to interfere with the androgen analyses and lead 
to an overestimation of the levels of the hormone measured. From previous unpublished data 
from the same laboratory that performed the analyses for this study we know that this 
procedure reduces the hormone levels measured by 20-40 percent in females.  
17-hydroxyprogesterone was measured to exclude that some of the participants 
suffered from congenital adrenal hyperplasisa and never thought to be included in the model. 
 
2.3.3 Physical performance 
Aerobic capacity was measured by a VO2max (relative = ml/kg/min) test. VO2 was measured 
through pulmonary gas exchange a treadmill using Oxycon Pro (Jaeger GmbH, Hoechberg, 
Germany) throughout the test with a sample frequency of 0.1 Hz. In addition heart rate was 
continuously measured. The participants had a ~15 minutes warm up on the treadmill (unless 
they requested another method) on approximately 60 % of their maximal heart rate. The test 
started with a 10.5 % incline with the speed increased stepwise by 1km/h every minute. The 
oxygen uptake was continuously measured and an average of the six latest 10-s consecutive 
measurements, in other words measurements from the last minute of the test, determined the 
VO2max. Maximal effort was considered when at least two of three following criteria were 
met: a plateau in VO2 was reached despite increased intensity/speed, a respiratory exchange 
ratio (the ratio between amount of CO2 exhaled and O2 inhaled in one breath) > 1.10 or blood 
lactate concentration > 8 mmol/L. To determine peak lactate blood samples were drawn 1 
minute after the test was finished and analysed consecutively on site (Lactate Pro LT-1710, 
ArkRay Inc, Kyoto, Japan). To be able to determine BMI height and weight was also 
recorded.  
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2.3.4 Other instruments 
This study is a part of a larger study where several other measurements were used and 
investigations performed. These were questionnaires determining handedness (The Edinburgh 
Handedness Inventory), examining eating behaviour (Eating Disorder Inventory, EDI 2), 
assessing anxiety and depression (Hospital Anxiety and Depression Scale, HADS) and 
sensation seeking (The Sensation Seeking Scale) were included as well as questionnaires 
about sexual orientation, their menstrual cycle, bodily hair growth (Ferriman-Gallwey score), 
sport history and goals, and living arrangements.  
Additional physical tests included maximal muscular power in the lower body 
measured by an explosive power squat jump on an AMTI BP6001200 Biomechanics Force 
Platform (Advanced Mechanical Technology, Inc., Massachusetts, USA) and maximal upper 
body effect tested by measuring acceleration in standard bench press with 50 % of body 
weight. A gynaecological examination (assessment by a gynaecologist in order to determine if 
the participants had PCOS) and full body Dual Energy X-ray Absortiometry (DEXA) scan 
using Hologic Discovery. The scan was performed to determine body composition and bone 
density. These results are reported elsewhere. 
 
2.4 Procedure 
The participants were recruited through their engagement with Olympiatoppen Midt-Norge. 
The participants were tested during the daytime of their choice. When they arrived at our 
physical test laboratory they were taken into a quiet room where they were given extensive 
information about the test (Appendix 2). They read an information sheet and signed the 
consent sheet (Appendix 3). Next, they were handed a package including all the 
questionnaires mentioned above. Filling out the questionnaires took from 35-60 min 
depending on the individual. After the questionnaires were finished they were taken to the 
laboratory to perform the physical test. First they were given about 15 minutes to warm up, 
before starting with the power squat jump, continuing with the bench press and ending with 
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the VO2max test and lactate tests. After having finished the questionnaires’ and tests the 
participants were told to visit the local hospital and have the blood drawn within 2-3 days, if 
possible. Gynaecological examination and DEXA scan was conducted on a different day at 
our local hospital (St. Olavs Hospital, Trondheim University Hospital).   
 
2.5 Ethics  
The study was approved by the Regional Committee for Research Ethics in Health Region IV 
in Norway. Participation was voluntary and an informed consent was signed by all women 
before inclusion in the study. The Helsinki Declaration was followed throughout the study. 
 
2.6 Statistics 
Values are given as means and standard deviation (SD). t test for independent samples was 
used to compare groups. To investigate the association between competitiveness and 
hormones multivariate linear regression analyses were used. In regression analyses variables 
suspected to associate with competitiveness and hormone levels were entered into the model. 
In addition a stepwise linear regression with the same variables was performed. All analyses 
were performed with the software IBM SPSS Statistics, version 19.0. P values less than .05 
were considered significant; no adjustment for multiple testing was performed.  
FTI, and not testosterone itself, was included in the regression model because it 
associates better to biological testosterone effect than total serum testosterone. SHBG was 
measured only to be able to compute the FTI in each participant.  
DHEAS, a precursor to androgens and estrogens, were also entered into the model. 
DHEAS and its de-sulphated form DHEA can be taken up in cells and converted to both 
androgens and estrogens (Labrie, 2004). Accordingly, we measured DHEAS to be able to 
adjust for this possible effect on competitiveness in the regression analyses. 
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BMI and age both affect hormone levels and should therefore be controlled for in the 
analyses (Dorgan et al., 1995; Ecochard, Marret, Barbato & Boehringer, 2000). 
VO2max and lactate were included in the analyses because it might be associated with 
competitiveness. At the top level in sports the goal is to win. To win and become better than 
the rest athletes have to train and be in a better physical condition than their competitors. 
VO2max and lactate are both well known measures expressing how good a shape someone is 
in and is widely used endurance in sports (as both soccer and cross country skiing are). As 
seen from the questions in SOQ competitiveness as well as the definition of competitiveness it 
has a lot to do with wanting to be the best and pushing yourself (Appendix 1). Since both 
VO2max and lactate is a measure of how well trained an individual is it could give 
information about how competitive they were. Being at the highest possible lactate and 
VO2max hurts, therefore we hypothesised that the more competitive individuals, those who 
want it the most, will also be the most competitive.  
 
3. RESULTS 
3.1 Competitiveness scores 
Figure 2 shows the distribution of participants competitiveness score. As seen in the Figure 2 
there were no major differences in competitiveness in our sample. The possible score ranged 
from 13 to 65, but in our sample all participants scored in the upper third of the 
competitiveness scale.  
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Figure 2. Distribution of the competitiveness score 
 
3.2 Participant characteristics 
The average BMI for all participants combined was 21.7 ± 1.7 kg/m
2
, the cross country skiers 
did in average have a lower BMI (20.5 ± 1.0 kg/m
2
) compared to the soccer players (22.2 ± 
1.8 kg/m
2
). The difference between the two groups was significant (t = 2.69, p <.05). The 
cross country skiers also ended up with a significantly lower lactate with an average of 9.9 ± 
1.7 mmol/L compared to the soccer players 11.5 ± 1.7 mmol/L( t = 2.32 p <.05). For the two 
groups combined the average lactate was 11.1 ± 1.9 mmol/L. For the entire group VO2max 
was measured to 54.3 ± 6.9 mL  min-1  kg -1, while the soccer players had an average of 
52.8 ± 6.8 mL  min-1  kg -1 and cross country skiers 57.8 ± 6.4 mL  min-1  kg -1. (t = -1.88, 
p 0.070). 
For DHEAS the values were 4.2 ± 1.6 mol/L for the whole group, for the soccer 
players 4.4 ± 1.7 mol/L and 3.5 ± 1.1 mol/L for the cross country skiers. For 
androstendione the group average was 9.6 ± 2.9 nmol/L, the average was 9.9 ± 2.9 nmol/L for 
the soccer players and 8.8 ± 2.9 nmol/L for the cross country skiers. The FTI group average 
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was .148 ± .109, .166 ± .120 was the soccer players average and .104 ± .059 was the cross 
country skiers average. An overview is given in Table 1.  
 
Table 1. Participant characteristics. 
 
 
All participants* 
(N  = 31) 
Soccer* 
(n = 22) 
Cross country 
skiing* 
(n = 9) 
P value** 
Age (years) 22.6 ± 3.6 22.6 ± 4.0 22.7 ± 3.0 .935 
BMI (kg/m
2
) 21.7 ± 1.7 22.2 ± 1.8 20.5 ± 1.0 .012*** 
Competitive index 59.9 ± 4.5 59.7 ± 4.1 60.6 ± 5.5 .631 
VO2max (mL  
min
-1  kg -1) 
54.3 ± 6.9 52.8 ± 6.8 57.8 ± 6.4 .070 
Lactate (mmol/L) 11.1 ± 1.9 11.5 ± 1.7 9.9 ± 1.7 .028*** 
DHEAS (mol/L) 4.2 ± 1.6 4.4 ± 1.7 3.5 ± 1.1 .164 
Androstenedione 
(nmol/L) 
9.6 ± 2.9 9.9 ± 2.9 8.8 ± 2.9 .375 
FTI  .148 ± .109 .166 ± .120 .104 ± .059 .150 
*Values are given as mean ± SD. 
**P value for t test for independent samples for difference between skiers and soccer players.  
*** p <.05 
 
3.3 Regression analyses 
In a multivariate linear regression model controlling for age, BMI, sports category, VO2max 
and DHEAS, FTI, androstenedione and lactate were found to be significantly associated with 
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competitiveness. The model explained almost 25 % of the variation in competitiveness with 
an adjusted R squared of .232 (SE 3.938).  
As seen in Table 2 androstenedione and lactate associate positively with 
competitiveness which is in accordance with our hypothesis. This means that women with the 
higher androstenedione levels and women that were able to go on exercising until they 
reached the higher lactate levels also were the women who scored the highest on the 
competitiveness scale. However, FTI has a significant negative correlation meaning that 
women with the higher FTI values were the least competitive ones. 
 
Table 2. Multivariate linear regression analyses of hormones and competitiveness.  
 Standardized 
Coefficients Beta 
t P value 
(Constant)  1.207 .240 
Age (years) -.021 -.124 .903 
BMI (kg/m
2
) -.063 -.338 .738 
VO2max (ml  min
-1  kg -1) .553 1.953 .064 
Lactate (mmol/L) .520 2.702 .013* 
Sports category (Soccer = 1, 
Cross country skiing = 2) 
-.232 -.807 .428 
Androstenedione (nmol/L) .675 2.539 .019* 
FTI  -.626 -2.178 .040* 
DHEAS (mol/L) -.012 -.052 .959 
Dependent Variable: Competitiveness 
* p < .05 
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4. DISCUSSION 
To the best of our knowledge this is the first study investigating the possible association 
between competitiveness and androgens in females. In a multivariate regression analyses in a 
group of female soccer and cross country skiing athletes we found that competitiveness was 
positively associated to androstenedione levels (p = .019) and maximum lactate levels 
achieved during an exercise test (p = .013), and negatively with associated with FTI (p = 
.040). The positive association between androstenedione and competitiveness was as 
anticipated. Androstenedione is a weak androgen; it binds less well than testosterone to the 
androgen receptor. However, when united with the receptor the cellular effects are as for 
testosterone. Perhaps more importantly, both DHEAS and androstenedione can be converted 
to testosterone within the cell. The newly converted testosterone may bind to the androgen 
receptor without being traceable in samples from circulating blood (Labrie, 2004). 
 The negative correlation between FTI, a measure of free biologically active 
testosterone, and competitiveness was unexpected. A possible explanation could be that 
testosterone may exert its effects by binding to other receptors than the known androgen 
receptors, or have non-receptor mediated effects. One other possibility is that it is not 
testosterone itself, that exert the effects, but its metabolites. 
 
4.1 Competitiveness and physical performance 
Lactate levels associated positively to competitiveness (p <. 05) as anticipated. We included 
lactate levels in the multivariate regression analyses because of the suspicion that it would be 
associated to competitiveness. We hypothesised that he most competitive individuals are more 
likely to have pushed themselves harder during all exercise and training for years and in every 
type of competition, both against themselves as well as against others. Accumulation of 
lactate in the blood stream during physical activity is a sign that the individual is pushing 
itself. High-intensity exercise gives an accumulation of lactic acid within the muscles being 
used. This causes a lowering in the muscles pH and onset of muscle fatigue and muscle pain 
(Hoffman, 2002). Training that stresses the anaerobe energy systems, like sprinting etc. 
improves the buffering capacity within the muscles and improves the muscles ability to 
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tolerate high concentrations of lactic acid. Individuals that are more competitive and therefore 
views every training session as a competition giving it their all will have higher intensity in 
training and therefore increase the amount of lactate the muscle can handle before the onset of 
fatigue. 
 In addition, they probably train their tolerance to pain during exercise. Because of that 
they can handle higher lactate levels than less competitive individuals who do not have the 
will and competitive instinct to keep on working when the muscles are fatigued. Our findings 
are in line with the observation of Martin et al. (1994) who investigated competitiveness, 
using the SOQ, and personal best times for distance runners and found a positive correlation. 
Individuals with the faster personal best times scored highest on competitiveness indicating 
that the fastest runners were indeed more competitive than the slower runners in the study by 
Martin et al. (1994). 
Our results are also in line with Rickenlund et al. (2003) who found that among female 
athletes a subgroup of girls with the highest androgen levels (total and free testosterone, 
androstendione, LH-FSH ratio) also had the highest VO2max values and the highest general 
performance values. Accordingly, our findings of a positive association between 
competitiveness and lactate and androstenedione levels are in line with the results from the 
Rickenlund et al (2003) study. However, in our study VO2max which is another measure of 
performance did not show a significant correlation with competitiveness. Though, it should be 
noted that there was a borderline positive association also between competitiveness and 
VO2max which further support the view that competitiveness is an important factor driving 
the female athletes towards performance and victory in competitions and it supports the 
rationale for studying the possible association between competitiveness and androgen levels 
in females. 
The borderline association between VO2max and competitiveness makes it difficult to 
draw conclusions. The borderline significance may be due to a small sample, but it may also 
be of other reasons. Some individuals have better physical predisposition for achieving high 
VO2max values than others. There are mainly two types of muscle fibres, slow-twitch fibres 
and fast-twitch fibres. The slow-twitch fibres are better for endurance performance since that 
is their primary responsibility while the fast-twitch fibres are better for performing rapid 
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movements (Fredberg, 2006). In other words, individuals with more slow-twitch fibres have 
better chances at achieving a high VO2max and thereby success in their sport activity. As 
mentioned in the introduction behaviour and success may affect androgen levels (Booth et al, 
1989; Carney, Cuddy and Yap, 2010; Mazur et al., 1997). With that in mind, in later studies it 
might be vice to use lactate as a test of how far the athletes can push themselves and not 
VO2max. 
 
4.2 Competitiveness and hormones 
The negative association between competitiveness and biological testosterone activity 
measured as FTI was contrary to our hypothesis and very surprising. Why one androgenic 
hormone, i.e. androstenedione show a positive correlation and FTI a negative correlation with 
competitiveness is hard to explain. Especially since all androgens bind to the androgen 
receptor to exert their biological effects. One possible explanation may be that androgens 
might exert effects by binding to other receptors or have non-receptor mediated effects. 
Another possibility is that it is not the hormones themselves, androstenedione or testosterone, 
which exerts the effects, but perhaps their metabolites (Edinger & Frye, 2007). Actually, in 
rats the testosterone metabolite androstanediol exerts effects on mating behaviour (Sánchez 
Montoya, Hernández, Barreto-Estrada, Ortiz & Jorge, 2010). Noteworthy, in the present study 
we performed precipitation procedures before testosterone and androstenedione analyses to 
avoid co-estimation of androgen metabolites. 
In women estrogens have been associated with drive and competition. Buser (2009) 
found that females were less competitive when oestrogen and progesterone levels were 
especially high due to birth control medication or natural differences. When the female sex 
hormones oestrogen and/or progesterone were low Buser found females to be more 
competitive and act more similar to males compared to when the concentration of oestrogen 
and/or progesterone were high. Buser found progesterone to have a negative impact on 
females’ competitiveness. He concluded that endocrine factors, and sex hormones in 
particular, seem to play an important role in explaining the gender difference in 
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competitiveness. Interestingly, in animal models androgen metabolites seems to interact with 
cerebral oestrogen receptors to exert their cerebral effects (Edinger & Frye, 2007).   
As mentioned in the introduction a substantial part of female athletes have PCOS 
(Fredberg, 2006; Hagmar et al., 2009; Rickenlund et al. 2003). Women with PCOS have 
increased androgen levels while oestrogen levels tend to be decreased. Accordingly, in female 
athletes elevated FTI may be a marker of low oestrogen levels. Then the inverse association 
between competitiveness and FTI may actually depend on low oestrogen levels and a possible 
biological oestrogen effect on competitiveness and not an effect of testosterone per see. This 
is in line with previous data showing that power motivation in females are positively 
correlated to oestradiol, the major female sex hormone, while in males power motivation is 
related to testosterone, the major male sex hormone (Schultheiss et al., 2003; Schultheiss et 
al., 2005; Stanton & Schultheiss, 2007; Stanton & Edelstein, 2009). However, Wood and 
Stanton (2012) stated that it is likely that high testosterone individuals of both sexes may be 
more motivated to pursue athletic competition and sports than normal or low testosterone 
individuals. 
 
4.3 Competitiveness, age and body mass index 
Age was included in the analyses because hormone levels change with age. Since the 
hypotheses was that hormones plays an important role in determining competitiveness 
controlling for factors associated with hormone levels was important (Dorgan et al., 1995). 
Controlling for body mass index (BMI) was done for the same reason.  
Martin et al. (1994) examined the relationship between competitiveness and age in 
distance runners between the age of 10-61 (58 male, 22 female). They found that 
competitiveness and age was negatively related meaning that competitiveness declined with 
age. On the contrary Cashdan (1998) did not find an age related difference in competitiveness 
in women, but did so in men. In men competitiveness declined with age, like Martin et al. 
(1994) also found. However, as seen in Table 2 we did not find an association between age 
and competitiveness in our study. This goes against Martin et al. (1994) but is in support of 
Cashdan (1998). One explanation to why we did not find a correlation between age and 
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competitiveness may be the relative narrow age span. Even if the age of the participants 
ranged from 18 to 34 years the mean of all participants age was 22.6 ± 3.6 years (Mdn = 21) 
(see Table 1). However, as seen in Figure 1, around one third of the participants were at the 
age of 21 and only four participants were between 27 and 34 years of age. A wider age span 
and more equal age distribution among the athletes might have given different results.  
Another possible explanation for the fact that Martin et al. (1994) found age 
differences in competitiveness and we did not could be that Martin et al. did not control for 
BMI, lactate, VO2max like it was done in the present study. It is also possible that only the 
most competitive females’ keeps competing at the highest level for years while the less 
competitive ones retire as athletes at an earlier age. In this way the average competitiveness of 
active female top athletes would not decline with increasing age of the active participants 
even when the competitiveness of each individual athlete decline with age. However, our 
results of no age/competitiveness correlation are supported by Cashdan (1998). 
BMI and competitiveness are not correlated as seen in Table 2. It was still important to 
use in the analysis since it has been reported that women’s hormone levels change with BMI 
(Ecochard et al., 2000). In future studies it may be wise to adjust for BMI or perhaps even 
better the subjects’ body composition as muscle is metabolically more active compared to fat 
tissue. 
 
4.4 A weakness in the competitiveness score? 
As mentioned earlier both Mazur and Booth (1998) and Archer (1991) agree upon the fact 
that studies using self-assessed aggressive predispositions and traits may be of limited 
relevance and the focus should be more towards concrete indicators of behaviour. If that is 
true for aggression, it could also be the case for other self-assessed predispositions and traits 
like for example competitiveness. On the other hand, competitiveness may be considered a 
more acceptable trait than aggressiveness. If so, one might expect that self-rated 
competitiveness should be more reliable than self-rated aggression. 
All the participants included in this study were athletes on a top level. Some of them 
may think of them themselves as more competitive than they really are, or maybe even feel 
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that they should be more competitive and answer accordingly. It might be that if we could 
have asked their trainers or peers to evaluate the team members’ competitiveness the outcome 
would have been different (Archer, 1991; Mazur & Booth, 1998). In her study, Cashdan 
(1995) also found that self-rated and peer-rated levels of status differed from one and other. 
High self-rated status was positively correlated with testosterone. It cannot be excluded that 
the same could be the case for competitiveness, and that the SOQ score gives a wrong image 
of competitiveness in our group.  
 
4.5 Individual versus team sport 
The fact that most of the participants were soccer players might influence our results. Besides 
being a competitive sport it is soccer is also a team sport. Previously it has been shown that 
the correlation between testosterone and performance differs for tasks that are performed 
alone and tasks performed in pairs (Mehta et al, 2009). Mehta et al. found that testosterone 
had a positive effect on performance in individual competition, as cross country skiing is, and 
a negative effect on performance when being forced to cooperate with others as is done (or at 
least should be done) in team sports as soccer. For soccer players team competence is 
important and may be more important than being ultimately competitive. The most 
competitive individuals might find it unsatisfying to work according to a team plan and turn to 
another sport. However, as seen in Table 1 we found no difference in competitiveness 
between soccer players and cross country skiers.  
 
4.6 Focus on females 
Most competitiveness research has been conducted on male athletes and to a large extent 
applied to both sexes, this it is not optimal. Males and females are biologically different and 
everything from training plans, competition strategies and meal plans should probably be 
adjusted according to gender. By taking a closer look at female competitiveness and what 
drives women to be competitive we can also hopefully better understand what drives them in 
other domains. This is important not only in a sports setting, but also in several other life 
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aspects. Understanding how, why and when females act and react different from men is key to 
help female athletes to improve their performance. It would be helpful for the trainers in their 
coaching of athletes as well as improving our understanding of gender differences in general. 
It might improve our general understanding of female athletes and possibly make us aware of 
what can be done to make female athletes stay in sports for a longer part of their life. 
 Acknowledging the sex difference in cognition is also important to more than just 
athletes and how to accomplish the best performance. So many things in life are built on 
competition. Everything from early childhood play to getting the dream job and being better 
than the rest is a lifelong competition.  
 
4.7 Strengths and weaknesses of the study 
One strength of this study is that competitiveness was measured with a questionnaire and 
factors that could influence competitiveness were added in the regression analyses. According 
to our view adjustment for factors that might affect hormone levels might be essential when 
assessing the possible association between hormone levels and psychological traits in females. 
In the present study competitiveness, hormones and physical measures are combined to create 
an overview of the factors that might affect competitiveness. Another major strength of our 
study is that the hormones were measured in blood samples and analysed in doubles which 
decreases measurement inaccuracy. In many other studies with testosterone as a factor the 
testosterone is sampled from the participants’ saliva. It is easier to do, but not as accurate. 
According to Granger et al. (2004) estimating total or free testosterone in the blood stream 
based on saliva levels has low accuracy for males, and even lower for females. They found 
the correlation between free testosterone and saliva testosterone in females to be poor (r = 
.37). Broadbent (2002) reports the same findings. An important aspect of our study is also the 
precipitation procedure to eliminate androgen metabolites before androgen analyses.  
The fact that the participants only represent two different sports, cross country skiing 
and soccer, and that both sports depend on high capacity in endurance and power, is also an 
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advantage. This makes the study group more homogenous while still having both an 
individual and a team sport represented.  
 A weakness of the study is the low number of participants and the somewhat skewed 
relationship between the two sports with 9 cross country skiers and 22 soccer players. With a 
larger number of participants VO2max could have become significantly related to 
competitiveness provided that the trend seen in our data was not coincidental.  
Another weakness may be the number of questionnaires for the participants to fill out. 
All in all the participants answered 7 questionnaires after one another. The SOQ was the 5th 
questionnaire to be answered. The participants may have been tired when answering the SOQ 
considering that some of the questionnaires before were quite extensive.  
Another weakness of the study is that estrogens were not measured. Studies indicate 
that estrogens might influence competitiveness in women (Buser, 2009). 
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5. CONCLUTION 
When adjusting for age, BMI, VO2max, lactate and sports category, we found that 
androstendione correlated positively and FTI negatively to competitiveness as measured by 
the sports orientation questionnaire. Why one androgen correlates positively to 
competitiveness while another correlates negatively is hard to explain, but one possible 
explanation is that androgens might have non-receptor mediated effects or exert their effect by 
binding to other receptors. Another possibility is that it is the androgen metabolites, and not 
the hormones, androstenedione or testosterone that exerts the effects.  
It might also be that we have been looking at the wrong hormones. Research has 
indicated that oestrogen and progesterone may influence competitiveness. When female 
hormone concentrations were low females’ behaviour has been more like men’s behaviour 
and the females were more competitive. A support for that theory might be the link between 
PCOS and top athletes. PCOS causes decreased oestrogen and increased androgens. Maybe 
research has focused on the wrong hormones, the androgens, while estrogens might possibly 
be more important in female athletes.  
It has previously been found that competitiveness declines with age. In this study 
however, no correlation between age and competitiveness was found.  
Lactate levels were associated with competitiveness. The most likely explanation 
being that the most competitive individuals are the individuals pushing themselves the hardest 
before they give up in any sport setting. As a result their metabolism would be more used to 
handling lactate and endure higher levels before having to slow down.  
As seen through the literature referred in this paper more focus is needed on the 
possible association, or even the possible cause and effect relationship between 
competitiveness and sex hormones, in particular in females. Studies combining 
competitiveness measured by different instruments and both androgens and estrogens 
measurements would help us understand the complex interaction between hormone effects 
and competitiveness. In women, taking a closer look at oestrogen and competitiveness has 
been suggested by several researchers and is needed as it may seem like the two are closely 
linked together.  
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APPENDIX II 
 
Forespørsel om deltagelse i forskningsprosjekt: 
”The Female Competitiveness Study” – er det sammenheng mellom hormonnivåer og 
konkurranseinstinkt hos kvinnelige toppidrettsutøvere? 
 
Bakgrunn og hensikt 
Toppidrettsutøvere presser sin fysiske og psykiske kapasitet til det ytterste. De fysiske og 
psykiske aspektene og sammenhengen med hormonnivåer har vært studert tidligere, spesielt 
hos menn. Sammenhengen mellom hormonnivåer, fysisk kapasitet og mentale faktorer hos 
kvinner er derimot lite studert. 
 Nivået av androgene hormoner (hormoner med testosteronvirkning) og spesielt 
testosteron er noe forhøyet hos kvinner med polycystisk ovarialsyndrom (PCOS). Kvinner 
med PCOS utgjør 10-15 % av kvinner i fruktbar alder, de synes å ha høyere 
konkurranseinstinkt og delta mer i idrett enn kvinner uten PCOS. Det synes også å være en 
svak sammenheng mellom PCOS, humørsvingninger og spiseadferd. Vi tror mye av dette kan 
ha sammenheng med de noe økte nivåene av hormoner med testosteronvirkning og at kvinner 
med økte testosteronnivå i spesiell grad trekkes mot idrett generelt og toppidrett spesielt.  
 Vi henvender oss til deg fordi du er en kvinnelig toppidrettsutøver for å be om ditt 
samtykke til deltakelse i dette forskningsprosjektet. Formålet med studien er å få økt 
kunnskap om sammenhengen mellom hormonnivåer hos kvinnelige toppidrettsutøvere og 
konkurranseinstinkt, muskelmasse, fysisk kapasitet, beintetthet, mentale forhold inkludert 
seksuell orientering og forekomsten av PCOS. Studien er et samarbeidsprosjekt mellom 
Avdeling for endokrinologi, St. Olavs hospital, Institutt for Bevegelsesvitenskap og 
Psykologisk Institutt, Norges teknisk- naturvitenskaplige universitet (NTNU) og 
Olympiatoppen Midt-Norge. Denne forespørselen går til toppidrettskvinner mellom 18 og 40. 
 
Hva innebærer deltagelse i studien? 
Den enkelte deltager vil få utført en DEXA-scan og taking av fastende blodprøve ved 
Avdeling for endokrinologi, St. Olavs hospital. Ved DEXA-scan ligger man stille i truse på 
ryggen i 10 minutter og det hele er helt smertefritt. Ved denne undersøkelsen bestemmes 
fettmasse, muskelmasse, beinmasse og beintetthet. I tillegg besvares spørreskjema om 
konkurranseinstinkt, spenningssøking, spiseadferd, mental helse og seksuell orientering. Vi 
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vil også registrere resultatene fra fysiske tester (VO2 max, laktat, maksimal muskelkraft ved 
spensthopp og benkpress). Medisinbruk, spesielt hormonpreparater (p-pille, p-stav, p-sprøyte, 
hormonspiral etc.) vil bli registrert. 
I tillegg håper vi å kunne tilby en gynekologisk undersøkelse for deltagerne i studien. 
 
Mulige fordeler og ulemper 
Som deltager har du mulighet til å bidra til ny kunnskap om sammenhengen mellom forhold 
knyttet til idrettsprestasjoner og toppidrettskvinners helse. Deltagelse i prosjektet medfører 
testing og analyse av blant annet beintetthet og muskelmasse. Lav beintetthet og 
menstruasjonsforstyrrelser kan være et problem hos kvinner som trener mye. Dersom dette 
påvises kan fagpersonene i prosjektgruppen vurdere spesielle tiltak dersom du ønsker det. 
Opplever du noen av spørsmålene som ubehagelige er det greit å unnlate å besvare 
dem. Data vil uansett ikke kunne spores tilbake til enkeltpersoner etter at de er registrert i en 
database. Vi har dessverre ikke anledning til å gi deltagerne økonomisk kompensasjon så 
deltagere i prosjektet må selv dekke eventuelle reiseutgifter.  
Den fysiske testingen vil bli gjennomført etter standard prosedyrer for slik fysiologisk 
testing og risikoen for at noe kan skje er minimal. VO2 max kan oppleves som anstrengende, 
men gi nyttig informasjon som kan brukes til videre treningsplanlegging.  Prestasjonstester vil 
også være standard og gjennomføres i tråd med trening du som utøver gjennomfører til daglig. 
Den eneste reelle forskjellen fra den daglige trening og testing er at dataene fra testene vil bli 
systematisert og lagret for brukt i prosjektet. 
 
Viktig! Dine forberedelser 
Blodprøvene vil bli tatt om morgenen, og du må faste 8 timer (dvs. fra midnatt) i forkant 
(inkludert røyk/snus-avhold). Dersom du er veldig tørst kan du evt. drikke et halvt glass vann 
morgenen før prøvene tas. 
 
Hva skjer med testene og informasjonen om deg? 
Dine resultater fra undersøkelsene vil bli behandlet i ikke identifiserbar form, dvs. uten navn, 
fødselsnummer eller andre identifiserende opplysninger. En kode knytter deg til dine 
opplysninger og prøver, gjennom en navneliste. Denne koden oppbevares uavhengig av selve 
databasen med alle opplysningene fra studien. Det er kun autorisert helsepersonell knyttet til 
prosjektet som har adgang til navnelisten og som eventuelt kan finne tilbake til deg. Det vil 
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ikke være mulig å identifisere deg i resultatene av studien når disse publiseres. Når prosjektet 
er avsluttet vil også koden som knytter deg til enkeltdata i databasen slettes.  
 Dersom du ønsker det kan vi gi deg tilbakemelding på testresultatene (som for 
eksempel kroppssammensetning, VO2 max, styrketestene, og evt. gynekologisk 
undersøkelse). Vi kan eventuelt også informere om eventuelle andre helseproblemer vi måtte 
påvise ved de undersøkelsene du gjennomgår. Dette vil foregå ved studiemedarbeiderne 
(kroppssammensetning, VO2 max, styrketestene) eller lege (gynekologisk undersøkelse, 
beintetthet, evt. andre forhold). Olympiatoppen, trenere eller andre vil ikke på noe tidspunkt 
få tilgang til informasjon om enkeltpersoner utover resultater fra de fysiske testene 
Olympiatoppen får tilgang på slik de gjør ved tilsvarende rutinetesting av utøvere.  
Studien er vurdert og godkjent av Regional komité for medisinsk forskningsetikk, 
Midt-Norge og vil bli gjennomført etter de regler og retningslinjer som er nedfelt i 
Helsinkideklarasjonen. Når studien er avsluttet vil resultatene bli publisert i et engelskspråklig 
internasjonalt medisinsk tidsskrift. 
 
Frivillig deltakelse 
Studien er frivillig, du kan på hvilken som helst tidspunkt trekke deg uten nærmere 
begrunnelse eller uten at det får noen negative konsekvenser for deg. Dette gjelder 
selvfølgelig også videre oppfølging fra Olympiatoppen. Dersom du trekker deg fra studien har 
du rett til innsyn i data registrert om deg. Du kan også trekke tilbake samtykket. Da vil alle 
innsamlede opplysninger om deg bli slettet og frosne blodprøver vil bli destruert med mindre 
opplysningene allerede er inngått i analyser eller brukt i vitenskaplige publikasjoner. 
Vi ber også om tillatelse til eventuelt å kontakte deg senere for oppfølgning. Dette er 
kun en forespørsel om vi får lov å ta kontakt med deg senere og ikke noe løfte fra deg om at 
du vil stille opp. Dette er ingen forutsetning for å delta i studien. Hvis du samtykker i å delta i 
studien må du undertegne en samtykkeerklæring lik den som er vedlagt før du deltar. 
Personopplysninger som knytter deg til data vil bli oppbevart til utgangen av 2014 og deretter 
slettet.  
 
Personvern 
Opplysninger som registreres om deg er:  
Helseopplysninger som du selv gir oss  
Opplysninger om din aktuelle medisinbruk 
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Resultater av blodprøveanalyser som tas 
Opplysninger om de tester og undersøkelser du gjennomgår 
Svar på de spørreskjema du besvarer 
Enkle kliniske data (høyde, vekt, blodtrykk etc.) 
 
Opplysningene legges inn i en database ved Enhet for anvendt klinisk forskning, NTNU i 
avidentifisert form, dvs. ikke med ditt navn eller fødselsnummer men kun med ditt 
deltagernummer. 
Alt personell som er involvert i studien og behandlingen av innsamlede data har taushetsplikt. 
Representanter for kontrollmyndigheter kan få utlevert studieopplysninger og gis innsyn i 
relevante deler av din journal. Dette er lovpålagt. Formålet er å kontrollere at 
studieopplysningene stemmer overens med tilsvarende opplysninger i din journal. Alle som 
får innsyn i informasjon om deg har taushetsplikt.  
 
Forskningsbiobank  
Blodprøvene som blir tatt og informasjonen utledet av dette materialet vil bli lagret i en 
forskningsbiobank som professor Sven M. Carlsen er ansvarlig for. De vil bli lagret i ikke 
personidentifiserbar stand, dvs. bare identifisert med deltagernummer.  
 
Utlevering av materiale og opplysninger til andre 
Hvis du sier ja til å delta i studien, gir du også ditt samtykke til at prøver og avidentifiserte 
opplysninger kan utleveres til våre samarbeidspartnere i forskning.  
 
Innsynsrett og oppbevaring av materiale 
Hvis du sier ja til å delta i studien, har du rett til å få innsyn i hvilke opplysninger som er 
registrert om deg. Du har videre rett til å få korrigert eventuelle feil i de opplysningene vi har 
registrert. Dersom du trekker deg fra studien, vil det ikke samles inn flere opplysninger eller 
mer materiale. Opplysninger som allerede er innsamlet fra deg vil ikke bli slettet.  
 
Finansiering  
Studien og biobanken er søkt finansiert av forskningsmidler fra Olympiatoppen og 
forskningsmidler som professor Sven M. Carlsen har innestående ved Unimed Innovation. 
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Sponsor (ansvarlig myndighet for studien) er Institutt for kreftforskning og 
molekylærmedisin, NTNU. 
 
Forsikring 
Du er forsikret gjennom Pasientskadeerstatningsordningen.  
 
 
Med vennlig hilsen  
_________________________ 
Sven M. Carlsen 
Professor dr. med. Prosjektleder 
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APPENDIX III 
 
SAMTYKKEERKLÆRING 
 
For deltakeren:  
Jeg bekrefter med dette at jeg har fått den informasjon jeg ønsker om og er villig 
til å delta i ”The Female Competitiveness Study”. Jeg vet at jeg uten nærmere 
begrunnelse kan trekke med fra studien på et hvert tidspunkt dersom jeg skulle 
ønske det uten at det vil ha konsekvenser for meg. Jeg er klar over at de 
innsamlede data brukes utelukkende til forskning og eventuell egen nytte ved 
økt kunnskap om meg selv. 
 
Jeg samtykker i å delta i prosjektet som innebærer følgende: 
- Testing av fysisk kapasitet (maksimal muskelkraft og VO2max) 
- Dexa-scan av kroppssammensetning  
- Blodprøvetaking for hormonanalyser  
- Spørreskjema angående konkurranseinstinkt, spenningssøking, 
spisevaner, mental helse og seksuell orientering 
- Gynekologisk undersøkelse (ingen betingelse for å delta i resten av 
studien) 
- Enkel klinisk undersøkelse (høyde, vekt, blodtrykk etc.) 
- Fotokopi av hendene 
 
 
 
Dersom du godkjenner at vi kontakter deg for eventuell oppfølgende forskning 
på et senere tidspunkt, vennligst kryss av her:     
  
 
Dersom du ønsker å bli kontaktet dersom blodprøver eller andre av 
undersøkelsene gir mistanke om spesielle medisinske problemer hos deg, 
vennligst kryss av her:   
 
 
 
 
Sted:___________________________             Dato:___/___- 2011 
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Navn:__________________________________________________ 
         (Deltakers fulle navn med BLOKKBOKSTAVER) 
 
 
                                  ______________________________________ 
                                                    Deltagers underskrift 
 
 
Jeg bekrefter med dette at deltageren har fått muntlig og skriftlig informasjon 
om studien, har fått svar på de muntlige spørsmål hun hadde og har underskrevet 
på denne deltagerformasjonen: 
 
Sted: __________________________               Dato:___/___- 2011 
 
Studiemedarbeider: ___________________________________________ 
 
 
Ansvarlige lege for undersøkelsen: 
Sven M. Carlsen,  Professor, Enhet for anvendt klinisk forskning, NTNU 
   Overlege, Avdeling for endokrinologi, St. Olavs hospital 
 
 
 
